Cargando…
A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645507/ http://dx.doi.org/10.1186/2051-1426-3-S2-P174 |
| _version_ | 1782400828219326464 |
|---|---|
| author | Sharma, Padmanee Grimm, Marc-Oliver Galsky, Matthew D Baron, Ari Bracarda, Sergio Siefker-Radtke, Arlene Lambert, Alexandre Azrilevich, Alex Retz, Margitta |
| author_facet | Sharma, Padmanee Grimm, Marc-Oliver Galsky, Matthew D Baron, Ari Bracarda, Sergio Siefker-Radtke, Arlene Lambert, Alexandre Azrilevich, Alex Retz, Margitta |
| author_sort | Sharma, Padmanee |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645507 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46455072015-11-20 A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent Sharma, Padmanee Grimm, Marc-Oliver Galsky, Matthew D Baron, Ari Bracarda, Sergio Siefker-Radtke, Arlene Lambert, Alexandre Azrilevich, Alex Retz, Margitta J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645507/ http://dx.doi.org/10.1186/2051-1426-3-S2-P174 Text en Copyright © 2015 Sharma et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Sharma, Padmanee Grimm, Marc-Oliver Galsky, Matthew D Baron, Ari Bracarda, Sergio Siefker-Radtke, Arlene Lambert, Alexandre Azrilevich, Alex Retz, Margitta A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent |
| title | A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent |
| title_full | A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent |
| title_fullStr | A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent |
| title_full_unstemmed | A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent |
| title_short | A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent |
| title_sort | phase ii, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645507/ http://dx.doi.org/10.1186/2051-1426-3-S2-P174 |
| work_keys_str_mv | AT sharmapadmanee aphaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT grimmmarcoliver aphaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT galskymatthewd aphaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT baronari aphaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT bracardasergio aphaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT siefkerradtkearlene aphaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT lambertalexandre aphaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT azrilevichalex aphaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT retzmargitta aphaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT sharmapadmanee phaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT grimmmarcoliver phaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT galskymatthewd phaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT baronari phaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT bracardasergio phaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT siefkerradtkearlene phaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT lambertalexandre phaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT azrilevichalex phaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent AT retzmargitta phaseiisinglearmstudyofnivolumabinpatientswithmetastaticorunresectableurothelialcancerwhohaveprogressedfollowingtreatmentwithaplatinumagent |